default author photo

Elizabeth J. Shpall

University of Texas at Houston - MD Anderson Cancer Center

SCHOLARLY PAPERS

3

DOWNLOADS

123

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Safety and Efficacy of a New High-Dose Chemotherapy Regimen of Panobinostat, Gemcitabine, Busulfan and Melphalan for 1st or 2nd Salvage Autologous Stem Cell Transplant for Patients with Refractory/Relapsed or High-Risk Myeloma: Matched Pair Comparisons with Concurrent Control Cohorts

Number of pages: 33 Posted: 10 Aug 2023
University of Texas at Houston - Department of Biostatistics, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Stem Cell Transplantation and Cellular Therapy, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Stem Cell Transplantation and Cellular Therapy, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center and University of Texas at Houston - MD Anderson Cancer Center
Downloads 72 (860,052)

Abstract:

Loading...

Myeloma, autologous stem-cell transplant, high-dose chemotherapy, phase 2 trial, matched pair comparison

2.

Cord-Derived Inkt Cells are Enriched with Human NKT10s and Mediate Immune-Regulation via Neuropilin-1

Number of pages: 50 Posted: 22 Jul 2025
University of Texas at Houston - MD Anderson Cancer Center, University of Houston, University of Texas at Houston - MD Anderson Cancer Center, University of Houston, Catholic University of Korea - Department of Hematology, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, Avera McKennan Hospital and University Health Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Houston, University of Texas at Houston - Department of Stem Cell Transplantation and Cellular Therapy, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center and University of Texas at Houston - MD Anderson Cancer Center
Downloads 27 (1,372,601)

Abstract:

Loading...

Cord-derived iNKT cells, NKT10, NRP1, immune-regulation, GVHD

3.

Treatment in Clinical Trials Could Mitigate Socioeconomic and Racial Disparities in Acute Myeloid Leukemia

Number of pages: 37 Posted: 27 Apr 2026
University of Texas at Houston - Department of Leukemia, University of Texas at Houston - MD Anderson Cancer Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, affiliation not provided to SSRN, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, affiliation not provided to SSRN, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, affiliation not provided to SSRN, University of Texas at Houston - Department of Leukemia, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Texas at Houston - Department of Biostatistics, affiliation not provided to SSRN, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Stem Cell Transplantation and Cellular Therapy, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Leukemia and University of Texas at Houston - Department of Leukemia
Downloads 24 (1,411,822)

Abstract:

Loading...

Area deprivation index, racial/ethnic disparity, clinical trials, stem cell transplant